STAC2
SH3 and cysteine-rich domain-containing protein 2
Also known as: 24b2, STAC2_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q6ZMT1
- Gene
- STAC2
- Ensembl
- ENSG00000141750
- Chromosome
- 17
- Canonical length
- 411 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
This gene encodes a protein containing an SH3 domain and a zinc finger domain. The encoded protein has been shown to regulate calcium channel inactivation in a human cell line. Reduced expression of this gene has been observed in human heart failure. [provided by RefSeq, May 2017]
Canonical amino-acid sequenceUniProt
411 residues, UniProt reviewed canonical sequence.
>Q6ZMT1|STAC2
1 MTEMSEKENE PDDAATHSPP GTVSALQETK LQRFKRSLSL KTILRSKSLE NFFLRSGSEL
61 KCPTEVLLTP PTPLPPPSPP PTASDRGLAT PSPSPCPVPR PLAALKPVRL HSFQEHVFKR
121 ASPCELCHQL IVGNSKQGLR CKMCKVSVHL WCSEEISHQQ CPGKTSTSFR RNFSSPLLVH
181 EPPPVCATSK ESPPTGDSGK VDPVYETLRY GTSLALMNRS SFSSTSESPT RSLSERDELT
241 EDGEGSIRSS EEGPGDSASP VFTAPAESEG PGPEEKSPGQ QLPKATLRKD VGPMYSYVAL
301 YKFLPQENND LALQPGDRIM LVDDSNEDWW KGKIGDRVGF FPANFVQRVR PGENVWRCCQ
361 PFSGNKEQGY MSLKENQICV GVGRSKDADG FIRVSSGKKR GLVPVDALTE ILocalizationUniProt · AlphaFold · HPA
Whether an antibody against STAC2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.53
- Highest tissue expression
- 112 nTPM
Expression across tissuesHPA
Tissue
- retina: 112 nTPM
- blood vessel: 79 nTPM
- breast: 52 nTPM
- skin: 49 nTPM
- cerebral cortex: 46 nTPM
- seminal vesicle: 22 nTPM
Single-cell type
- müller glia: 960 nCPM
- breast lactating cells: 209 nCPM
- breast secretory cells: 183 nCPM
- renal collecting duct intercalated cells: 132 nCPM
- salivary myoepithelial cells: 131 nCPM
- breast myoepithelial cells: 105 nCPM
Immune cell
- basophil: 0 nTPM
- classical monocyte: 0 nTPM
- eosinophil: 0 nTPM
- gdT-cell: 0 nTPM
- intermediate monocyte: 0 nTPM
- MAIT T-cell: 0 nTPM
Brain region
- cerebral cortex: 125 nTPM
- white matter: 72 nTPM
- pons: 66 nTPM
- hypothalamus: 50 nTPM
- midbrain: 40 nTPM
- medulla oblongata: 37 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about STAC2.
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 79 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.1
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 2% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of protein localization to plasma membrane
- positive regulation of voltage-gated calcium channel activity
- skeletal muscle contraction
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- SH3 domain
- Protein kinase C-like, phorbol ester/diacylglycerol-binding domain
- SH3-like domain superfamily
- STAC1/2/3
- C1-like domain superfamily
- Phorbol esters/diacylglycerol binding domain (C1 domain)
- Variant SH3 domain
- Variant SH3 domain
- Unstructured on SH3 and cysteine-rich domain-containing protein 2
- Stac2, SH3 domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of STAC2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads STAC2 as an antibody target. Whether an autoantibody or antibody against STAC2 could matter depends on whether native STAC2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
STAC2 is annotated at the cell surface, where native STAC2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label STAC2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...